DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/r5qklh/global_fabry) has announced the addition of the "Global Fabry Disease Market 2015-2019" report to their offering.
The Global Fabry Disease market to grow at a CAGR of 18.08% over the period 2014-2019.
This report covers the present scenario and the growth prospects of the Global Fabry Disease market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various innovator drugs available in the market for the treatment of Fabry disease.
One key trend in the market is an increase in regulatory assistance in emerging nations. Regulatory bodies are steadily working toward developing guidelines and providing assistance to drug manufacturers to promote research in this area.
According to the report, special provisions for orphan drugs are one of the major drivers of this market. Special incentives in the form of funding, guidance, and market exclusivity offer an attractive opportunity to vendors to conduct research in this area.
Further, the report states that one of the main challenges that the market confronts is the limited patient population. The availability of a limited treatment group may prolong the time period by which a vendor could recover the R&D expenses of the drug. Restricted patient population might also hinder effective evaluation of drugs based on clinical trials.
Key Topics Covered:
- Executive Summary
- List of Abbreviations
- Scope of the Report
- Market Research Methodology
- Disease Overview
- Market Landscape
- Market Segmentation by Cell Line Used for Manufacturing the Drug
- Geographical Segmentation
- Buying Criteria
- Market Growth Drivers
- Drivers and their Impact
- Market Challenges
- Impact of Drivers and Challenges
- Market Trends
- Trends and their Impact
- Vendor Landscape
- Pipeline Analysis
- Fabry Registry
- Key Vendor Analysis
For more information visit http://www.researchandmarkets.com/research/r5qklh/global_fabry